Home Cancer therapy deal with Bristol-Myers Squibb boosts Five Prime drug
 

Keywords :   


Cancer therapy deal with Bristol-Myers Squibb boosts Five Prime drug

2014-11-25 08:34:39| Biotech - Topix.net

Five Prime Therapeutics Inc. snagged a deal with Bristol-Myers Squibb Co. around one of the leading drugs in the emerging class of cancer-fighting drugs known as immune checkpoint inhibitors.

Tags: deal drug prime cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.06Potential Tropical Cyclone One Graphics
18.06Atlantic Tropical Weather Outlook
18.06Potential Tropical Cyclone One Public Advisory Number 1A
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Could brain-like computers be a 'competition killer'?
18.06Low investment blocking UK growth, says think tank
18.06Eastern North Pacific Tropical Weather Outlook
18.06Boeing boss admits culture 'far from perfect'
More »